Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension.
作者信息
Ogilvie R I, Burgess E D, Cusson J R, Feldman R D, Leiter L A, Myers M G
机构信息
Toronto Hospital, Western Division, ON.
出版信息
CMAJ. 1993 Sep 1;149(5):575-84.
Abstract
摘要
相似文献
1
2
[Arterial essential hypertension and associated pathologies].[动脉性原发性高血压及相关病理情况]
J Med Liban. 1999 Nov-Dec;47(6):343-8.
3
4
Round table 2. First-line drugs: the position of the World Health Organization-International Society of Hypertension.圆桌会议2. 一线药物：世界卫生组织-国际高血压学会的立场
J Hypertens Suppl. 1993 Dec;11(5):S381-3.
5
[Results of the 3rd Consensus Conference on "Individualized Therapy of Hypertension" and brief explanation of individual evaluation].["第三届'高血压个体化治疗'共识会议结果及个体评估简要说明"]
Wien Med Wochenschr. 1995;145(15-16):339-49.
6
2003 Canadian hypertension recommendations. It's not all old hat.2003年加拿大高血压治疗建议。并非全是老生常谈。
Can Fam Physician. 2004 Apr;50:589-90.
7
Antihypertensive treatment, adiponectin and cardiovascular risk.
J Hum Hypertens. 2007 Jan;21(1):8-11. doi: 10.1038/sj.jhh.1002113. Epub 2006 Oct 26.
8
[Drug treatment of pre-hypertension--pro].高血压前期的药物治疗——支持观点
Dtsch Med Wochenschr. 2008 Jun;133(24):1304. doi: 10.1055/s-2008-1077257.
9
10
[Antihypertensive treatment in the type 2 diabetic].2型糖尿病患者的降压治疗
Nephrologie. 2000;21(4):203-4.
引用本文的文献
1
Chemical Composition and Vasorelaxant and Antispasmodic Effects of Essential Oil from Rosa indica L. Petals.月季花瓣精油的化学成分及其血管舒张和抗痉挛作用
Evid Based Complement Alternat Med. 2015;2015:279247. doi: 10.1155/2015/279247. Epub 2015 Aug 19.
2
Efficacy and tolerability of a β-1 selective β blocker, bisoprolol, as a first-line antihypertensive in Indian patients diagnosed with essential hypertension (BRIGHT): an open-label, multicentric observational study.β-1选择性β受体阻滞剂比索洛尔作为印度原发性高血压患者一线降压药物的疗效和耐受性（BRIGHT）：一项开放标签、多中心观察性研究
BMJ Open. 2012 May 14;2(3). doi: 10.1136/bmjopen-2011-000683. Print 2012.
3
Canadian Hypertension Education Program: the evolution of hypertension management guidelines in Canada.加拿大高血压教育计划：加拿大高血压管理指南的演变
Can J Cardiol. 2008 Jun;24(6):477-81. doi: 10.1016/s0828-282x(08)70621-4.
4
Do beta-blockers have a role in treating hypertension? No.β受体阻滞剂在治疗高血压方面有作用吗？没有。
Can Fam Physician. 2007 Apr;53(4):614-21.
5
First-line first? Trends in thiazide prescribing for hypertensive seniors.一线治疗优先？老年高血压患者噻嗪类药物处方的趋势。
PLoS Med. 2005 Apr;2(4):e80. doi: 10.1371/journal.pmed.0020080. Epub 2005 Apr 26.
6
Actual practice in hypertension: implications for persistence with and effectiveness of therapy.
Curr Hypertens Rep. 2001 Dec;3(6):481-7. doi: 10.1007/s11906-001-0010-1.
7
8
Clinical problem solving based on the 1999 Canadian recommendations for the management of hypertension.基于1999年加拿大高血压管理建议的临床问题解决
CMAJ. 1999;161 Suppl 12(12):S18-22.
9
10
A novel method of guideline development for the diagnosis and management of mild to moderate hypertension.一种用于轻至中度高血压诊断和管理的新型指南制定方法。
Br J Gen Pract. 1999 Mar;49(440):175-9.
本文引用的文献
1
2
Report of the Canadian Hypertension Society Consensus Conference: 1. Introduction.加拿大高血压协会共识会议报告：1. 引言。
CMAJ. 1993 Aug 1;149(3):289-93.
3
Treatment of mild hypertension: a five year controlled drug trial. The Oslo study.轻度高血压的治疗：一项为期五年的对照药物试验。奥斯陆研究。
Am J Med. 1980 Nov;69(5):725-32. doi: 10.1016/0002-9343(80)90438-6.
4
Serum lipoprotein levels during chlorthalidone therapy. A Veterans Administration-National Heart, Lung, and Blood Institute cooperative study on antihypertensive therapy: mild hypertension.氯噻酮治疗期间的血清脂蛋白水平。一项退伍军人管理局-国家心肺血液研究所关于降压治疗的合作研究：轻度高血压。
JAMA. 1980 Oct 10;244(15):1691-5. doi: 10.1001/jama.244.15.1691.
5
Effects of diuretic and beta-blocker therapy in the Medical Research Council Trial.医学研究委员会试验中利尿剂和β受体阻滞剂疗法的效果。
Am J Med. 1984 Feb 27;76(2A):45-51. doi: 10.1016/0002-9343(84)90956-2.
6
Report of the Canadian Hypertension Society's consensus conference on the management of mild hypertension.加拿大高血压协会轻度高血压管理共识会议报告
Can Med Assoc J. 1984 Nov 1;131(9):1053-7.
7
Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.早期积极的降压治疗可降低糖尿病肾病患者肾功能下降的速率。
Lancet. 1983 May 28;1(8335):1175-9. doi: 10.1016/s0140-6736(83)92462-5.
8
Plasma lipoprotein levels in treated and untreated hypertensive men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study.
Arteriosclerosis. 1985 Jul-Aug;5(4):391-6. doi: 10.1161/01.atv.5.4.391.
9
Rules of evidence and clinical recommendations on the use of antithrombotic agents.抗血栓药物使用的证据规则及临床建议。
Chest. 1986 Feb;89(2 Suppl):2S-3S.
10
Hypertension and the kidney.高血压与肾脏
Nephron. 1987;47 Suppl 1:62-7. doi: 10.1159/000184556.
Zotero 插件